Anti-anaerobic activity of antibacterial agents
- 24 February 2001
- journal article
- review article
- Published by Taylor & Francis in Expert Opinion on Investigational Drugs
- Vol. 10 (2) , 239-267
- https://doi.org/10.1517/13543784.10.2.239
Abstract
The first very effective bactericidal anti-anaerobic drug was metronidazole, introduced in clinical practice in the early 1980s. Sometimes penicillin G and chloramphenicol were used successfully in some anaerobic infections. However, this result was most likely due to Gram-positive anaerobic infections (e.g., Clostridium perfringens). Very rapidly, the anti-anaerobic armamentarium was extended with clindamycin, cefoxitin, imipenem and co-amoxyclav or piperacillin-tazobactam. The resistance rate to metronidazole and imipenem remains low but clindamycin has seen an importance decrease in bacterial susceptibility. New additional drugs could be very helpful to overcome resistance and adverse events. The novelties in this field are fluoroquinolones, which exhibit a good activity against Gram-positive cocci and anaerobes.Keywords
This publication has 78 references indexed in Scilit:
- Comparative In Vitro Activities of Clinafloxacin and Trovafloxacin against 1,000 Isolates of Bacteroides fragilis Group: Effect of the Medium on Test ResultsAntimicrobial Agents and Chemotherapy, 2000
- In vitro activity of quinupristin/dalfopristin (RP 59500) against a large collection of infrequently isolated or tested speciesDiagnostic Microbiology and Infectious Disease, 1996
- A five-year multicenter study of the susceptibility of the Bacteroides fragilis group isolates to cephalosporins, cephamins, penicillins, clindamycin, and metronidazole in the United StatesDiagnostic Microbiology and Infectious Disease, 1994
- The in-vitro activity of L-627 against anaerobic bacteriaJournal of Antimicrobial Chemotherapy, 1994
- L-627, a novel carbapenem: in-vitro activity against anaerobesJournal of Antimicrobial Chemotherapy, 1994
- In vitro activity of L-627 against anaerobic bacteriaEuropean Journal of Clinical Microbiology & Infectious Diseases, 1992
- Antibiotic sensitivity of theBacteroides fragilis group in EuropeEuropean Journal of Clinical Microbiology & Infectious Diseases, 1992
- β-Lactamase production, β-lactam sensitivity and resistance to synergy with clavulanate of 737 Bacteroides fragilis group organisms from thirty-three US centresJournal of Antimicrobial Chemotherapy, 1990
- In vitro activity of meropenem (SM-7338), imipenem, and five other antibiotics against anaerobic clinical isolatesDiagnostic Microbiology and Infectious Disease, 1990
- In-vitro activity of pristinamycin and its components against Gram-negative anaerobic bacilli and Gardnerella vaginalisJournal of Antimicrobial Chemotherapy, 1989